Autopsy report · NCT04796584
Efficacy of COVID-19 Vaccination in Patients With Multiple Sclerosis Treated With Immune Modulating Medication
Cause of deathOther
“Enrollment paused for greater than 6 months, data would not be relevant as enrollment took longer than expected.”
Life of this trial
- Registered 1 year 4 months before it started.
- Ran for about 3 months before it stopped.
- 20 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Providence Health & Services
- Sponsor type
- University, hospital or other
- Conditions
- Multiple Sclerosis
- Interventions
- Analysis of cell-mediated and antibody-mediated immunity to SARS-CoV-2 virus
- Participants
- 20
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer
“The study was halted because enrollment was too slow” - Corticosteroids for Immune Reconstitution Inflammatory Syndrome (IRIS)
“This study was stopped prematurely due to lack of enrollment within a 1-5-year period.” - Hand Injected Ventriculography vs. Power Injected Left Ventriculography
“Study was stopped due to low enrollment.” - The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
“Due to lower than anticipated enrollment number, this study was stopped.” - Heliox-Powered Albuterol Therapy in the Treatment of Children Admitted With Acute Asthma Exacerbation
“Study was stopped after interim analysis and slow enrollment.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.